Easterly Investment Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,000
| Closed | -$215K | – | 205 |
|
|
2025
Q1 | $215K | Sell |
27,000
-18,000
| -40% | -$143K | 0.02% | 182 |
|
|
2024
Q4 | $244K | Sell |
45,000
-102
| -0.2% | -$554 | 0.02% | 189 |
|
|
2024
Q3 | $326K | Sell |
45,102
-91,500
| -67% | -$661K | 0.03% | 188 |
|
|
2024
Q2 | $1.48M | Buy |
136,602
+27,000
| +25% | +$293K | 0.13% | 129 |
|
|
2024
Q1 | $2.05M | Sell |
109,602
-13,041
| -11% | -$244K | 0.16% | 118 |
|
|
2023
Q4 | $2.66M | Sell |
122,643
-73,000
| -37% | -$1.58M | 0.28% | 87 |
|
|
2023
Q3 | $4.03M | Buy |
195,643
+144,522
| +283% | +$2.97M | 0.44% | 76 |
|
|
2023
Q2 | $2.4M | Sell |
51,121
-29,524
| -37% | -$1.39M | 0.21% | 102 |
|
|
2023
Q1 | $3.38M | Buy |
80,645
+2,000
| +3% | +$83.9K | 0.3% | 86 |
|
|
2022
Q4 | $3M | Buy |
78,645
+14,980
| +24% | +$571K | 0.26% | 91 |
|
|
2022
Q3 | $2.49M | Sell |
63,665
-2,500
| -4% | -$97.9K | 0.24% | 95 |
|
|
2022
Q2 | $2.14M | Buy |
66,165
+32,555
| +97% | +$1.05M | 0.19% | 102 |
|
|
2022
Q1 | $1.11M | Buy |
+33,610
| New | +$1.11M | 0.08% | 135 |
|